<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Deng H</submitter><pubmed_abstract>Prolyl hydroxylase domain protein 2 (PHD2) is one of the intracellular oxygen sensors that mediates proteasomal degradation of hypoxia-inducible factor (HIF)-α via hydroxylation under normoxic conditions. Because of its canonical function in the hypoxia signaling pathway, PHD2 is generally regarded as a tumor suppressor. However, the effects of PHD2 in tumorigenesis are not entirely dependent on HIF-α. Based on analysis of data from the Cancer Genome Atlas (TCGA) database, we observed that the expression of &lt;i>PHD2&lt;/i> is upregulated in non-small cell lung cancer (NSCLC), which accounts for approximately 80-85% of lung cancers. This suggests that PHD2 may play an important role in NSCLC. However, the function of PHD2 in NSCLC remains largely unknown. In this study, we established &lt;i>PHD2&lt;/</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1370393</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11240288</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners.</pubmed_title><pmcid>PMC11240288</pmcid><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Deng H</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners.</name><description>Prolyl hydroxylase domain protein 2 (PHD2) is one of the intracellular oxygen sensors that mediates proteasomal degradation of hypoxia-inducible factor (HIF)-α via hydroxylation under normoxic conditions. Because of its canonical function in the hypoxia signaling pathway, PHD2 is generally regarded as a tumor suppressor. However, the effects of PHD2 in tumorigenesis are not entirely dependent on HIF-α. Based on analysis of data from the Cancer Genome Atlas (TCGA) database, we observed that the expression of &lt;i>PHD2&lt;/i> is upregulated in non-small cell lung cancer (NSCLC), which accounts for approximately 80-85% of lung cancers. This suggests that PHD2 may play an important role in NSCLC. However, the function of PHD2 in NSCLC remains largely unknown. In this study, we established &lt;i>PHD2&lt;/</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-01T07:14:54.526Z</modification><creation>2026-04-08T10:17:45.066Z</creation></dates><accession>S-EPMC11240288</accession><cross_references><pubmed>39007099</pubmed><doi>10.3389/fonc.2024.1370393</doi></cross_references></HashMap>